198 related articles for article (PubMed ID: 35107804)
1. Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
Drosos AA; Pelechas E; Drossou V; Voulgari PV
Rheumatol Ther; 2022 Apr; 9(2):379-389. PubMed ID: 35107804
[TBL] [Abstract][Full Text] [Related]
2. Colchicine in COVID-19: an Old Drug, New Use.
Schlesinger N; Firestein BL; Brunetti L
Curr Pharmacol Rep; 2020; 6(4):137-145. PubMed ID: 32837853
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 in patients with gout on colchicine.
Pelechas E; Drossou V; Voulgari PV; Drosos AA
Rheumatol Int; 2021 Aug; 41(8):1503-1507. PubMed ID: 34089357
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review.
Nas K; Eryilmaz N; Geyik MF; Altaş A
Rheumatol Int; 2021 Apr; 41(4):811-817. PubMed ID: 33611657
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever.
Marinelli F; Caporilli C; Titolo A; Rigante D; Esposito S
Pharmacol Res; 2022 Aug; 182():106293. PubMed ID: 35690330
[TBL] [Abstract][Full Text] [Related]
6. The Use of Colchicine in Cardiovascular Diseases: A Systematic Review.
Siak J; Flint N; Shmueli HG; Siegel RJ; Rader F
Am J Med; 2021 Jun; 134(6):735-744.e1. PubMed ID: 33609528
[TBL] [Abstract][Full Text] [Related]
7. A Review of the Rational and Current Evidence on Colchicine for COVID-19.
Ghaith HS; Gabra MD; Nafady MH; Elshawah HE; Negida A; Mushtaq G; Kamal MA
Curr Pharm Des; 2022; 28(39):3194-3201. PubMed ID: 34895117
[TBL] [Abstract][Full Text] [Related]
8. Colchicine in Cardiovascular Disease: In-Depth Review.
Deftereos SG; Beerkens FJ; Shah B; Giannopoulos G; Vrachatis DA; Giotaki SG; Siasos G; Nicolas J; Arnott C; Patel S; Parsons M; Tardif JC; Kovacic JC; Dangas GD
Circulation; 2022 Jan; 145(1):61-78. PubMed ID: 34965168
[TBL] [Abstract][Full Text] [Related]
9. Colchicine - From rheumatology to the new kid on the block: Coronary syndromes and COVID-19.
Surma S; Basiak M; Romańczyk M; Filipiak KJ; Okopień B
Cardiol J; 2023; 30(2):297-311. PubMed ID: 34642922
[TBL] [Abstract][Full Text] [Related]
10. Isolating Colchicine in 19th Century: An Old Drug Revisited.
Karamanou M; Tsoucalas G; Pantos K; Androutsos G
Curr Pharm Des; 2018; 24(6):654-658. PubMed ID: 29336251
[TBL] [Abstract][Full Text] [Related]
11. Colchicine in the management of Covid-19: With or lieu of evidence.
Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI
J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235
[TBL] [Abstract][Full Text] [Related]
12. Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.
Rahhal A; Najim M; Aljundi AH; Mahfouz A; Alyafei SM; Awaisu A; Habib MB; Obeidat I; Faisal MM; Alanzi MA; Nair AP; Elhassan A; Al-Dushain A; Abdelmajid AA; Abdelgader AE; Moursi AMA; Alharafsheh AEN; Kamar MRA; Goravey W; Omar AS; Abukhattab M; Khatib MY; Mohamedali MG; AlMaslamani MAR; Alemadi S
Medicine (Baltimore); 2022 Sep; 101(39):e30618. PubMed ID: 36181009
[TBL] [Abstract][Full Text] [Related]
13. [Colchicine: old medication with new benefits : Use in rheumatology and beyond].
Boyadzhieva Z; Ruffer N; Krusche M
Z Rheumatol; 2021 Sep; 80(7):647-657. PubMed ID: 34097101
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients.
Kaya Akca U; Sener S; Balık Z; Gurlevik S; Oygar PD; Atalay E; Cuceoglu MK; Basaran O; Batu ED; Teksam O; Bilginer Y; Ozsurekci Y; Ozen S
Mod Rheumatol; 2022 Feb; 32(2):467-472. PubMed ID: 34897503
[TBL] [Abstract][Full Text] [Related]
15. Repurposing colchicine's journey in view of drug-to-drug interactions. A review.
Vrachatis DA; Papathanasiou KA; Giotaki SG; Iliodromitis KE; Papaioannou TG; Stefanini GG; Cleman M; Siasos G; Reimers B; Lansky A; Tardif JC; Deftereos SG; Giannopoulos G
Toxicol Rep; 2021; 8():1389-1393. PubMed ID: 34285885
[TBL] [Abstract][Full Text] [Related]
16. Colchicine's Effects on Electrocardiographic Parameters in Newly Diagnosed Familial Mediterranean Fever Patients : Colchicine may have Favourable Effects on Parameters Related to Ventricular Arrhythmias in New Diagnosed Familial Mediterranean Fever.
Ocal AG; Ocal L; Kup A; Eren H; Tezcan ME
Z Rheumatol; 2020 Mar; 79(2):210-215. PubMed ID: 31065792
[TBL] [Abstract][Full Text] [Related]
17. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
Demidowich AP; Levine JA; Apps R; Cheung FK; Chen J; Fantoni G; ; Patel TP; Yanovski JA
Int J Obes (Lond); 2020 Aug; 44(8):1793-1799. PubMed ID: 32461554
[TBL] [Abstract][Full Text] [Related]
18. Familial Mediterranean Fever and COVID-19: Friends or Foes?
Stella A; Lamkanfi M; Portincasa P
Front Immunol; 2020; 11():574593. PubMed ID: 33072117
[TBL] [Abstract][Full Text] [Related]
19. Colchicine - new horizons for an ancient drug. Review based on the highest hierarchy of evidence.
Schattner A
Eur J Intern Med; 2022 Feb; 96():34-41. PubMed ID: 34657777
[TBL] [Abstract][Full Text] [Related]
20. The impact of COVID-19 on familial Mediterranean fever: a nationwide study.
Günendi Z; Yurdakul FG; Bodur H; Cengiz AK; Uçar Ü; Çay HF; Şen N; Keskin Y; Gürer G; Melikoğlu MA; Altıntaş D; Deveci H; Baykul M; Nas K; Çevik R; Karahan AY; Toprak M; Ketenci S; Nayimoğlu M; Sezer İ; Demir AN; Ecesoy H; Duruöz MT; Yurdakul OV; Sarıfakıoğlu AB; Ataman Ş
Rheumatol Int; 2021 Aug; 41(8):1447-1455. PubMed ID: 34032894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
